Covered recipient · General Payments record
JULIE A JAFFRAY
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
General Payments · PY2018–2024
$88,590.58
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Grant | $19,800.00 | 2 |
| Travel and Lodging | $6,488.69 | 2 |
| Food and Beverage | $241.60 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $19,859.92 | 3 |
| Octapharma USA, Inc. | $6,488.69 | 2 |
| GENZYME CORPORATION | $131.43 | 1 |
| Genentech, Inc. | $50.25 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | $28.97 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133042629 | CMS |
| Genentech, Inc. | $21.28 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133042625 | CMS |
| GENZYME CORPORATION | $131.43 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139739594 | CMS |
| Novo Nordisk Inc | $15,840.00 | 07/11/2024 | Grant | Undisputed | 01/23/2026 | 1096731186 | CMS |
| Novo Nordisk Inc | $59.92 | 09/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097050395 | CMS |
| Novo Nordisk Inc | $3,960.00 | 10/25/2024 | Grant | Undisputed | 01/23/2026 | 1096590869 | CMS |
| Octapharma USA, Inc. | $6,071.00 | 09/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142315635 | CMS |
| Octapharma USA, Inc. | $417.69 | 09/28/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1142315637 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.